Feng Chen

3PUBLICATIONS
7CO-AUTHORS
Innate immunityPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 08, 2025
Phase 2 Trial of PD-1 Inhibitor Sintilimab in Recurrent/Progressive Meningioma.

Yali Wang, Can Wang, Shuo Yin

|Apr 02, 2023
A lipid metabolism-based prognostic risk model for HBV-related hepatocellular carcinoma.

Lili Zhou, Shaohuai Xia, Yaoyao Liu

Pageof 1